Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted Agent

PHASE4CompletedINTERVENTIONAL
Enrollment

255

Participants

Timeline

Start Date

November 9, 2015

Primary Completion Date

March 27, 2019

Study Completion Date

March 15, 2021

Conditions
Prostate Cancer Metastatic
Interventions
DRUG

cabazitaxel XRP6258

Pharmaceutical form: solution Route of administration: intravenous

DRUG

enzalutamide

Pharmaceutical form: capsule Route of administration: oral

DRUG

abiraterone acetate

Pharmaceutical form: tablet Route of administration: oral

DRUG

prednisone

Pharmaceutical form: tablet Route of administration: oral

Trial Locations (65)

101

Investigational Site Number 352001, Reykjavik

1000

Investigational Site Number 056003, Brussels

1070

Investigational Site Number 056007, Brussels

1090

Investigational Site Number 040003, Vienna

Investigational Site Number 040004, Vienna

1714

Investigational Site Number 578001, Grålum

3000

Investigational Site Number 056005, Leuven

4010

Investigational Site Number 040002, Linz

7006

Investigational Site Number 578002, Trondheim

8310

Investigational Site Number 056013, Bruges

9000

Investigational Site Number 056001, Ghent

11528

Investigational Site Number 300001, Athens

13273

Investigational Site Number 250004, Marseille

14059

Investigational Site Number 203003, Prague

14179

Investigational Site Number 276008, Berlin

15125

Investigational Site Number 300005, Marousi, Athens

18107

Investigational Site Number 276010, Rostock

22190

Investigational Site Number 250014, Plérin

23538

Investigational Site Number 276025, Lübeck

25123

Investigational Site Number 380004, Brescia

28041

Investigational Site Number 724004, Madrid

28046

Investigational Site Number 724002, Madrid

30460

Investigational Site Number 203002, Pilsen

34298

Investigational Site Number 250011, Montpellier

37044

Investigational Site Number 250008, Tours

37075

Investigational Site Number 276007, Göttingen

39120

Investigational Site Number 276004, Magdeburg

41013

Investigational Site Number 724003, Seville

45136

Investigational Site Number 276023, Essen

47179

Investigational Site Number 276022, Duisburg

48149

Investigational Site Number 276006, Münster

56429

Investigational Site Number 300004, Thessaloniki

60488

Investigational Site Number 276002, Frankfurt am Main

63011

Investigational Site Number 250010, Clermont-Ferrand

63739

Investigational Site Number 276028, Aschaffenburg

65653

Investigational Site Number 203005, Brno

67091

Investigational Site Number 250009, Strasbourg

68167

Investigational Site Number 276018, Mannheim

69373

Investigational Site Number 250006, Lyon

72076

Investigational Site Number 276011, Tübingen

72622

Investigational Site Number 276003, Nürtingen

75005

Investigational Site Number 250013, Paris

75010

Investigational Site Number 250007, Paris

75015

Investigational Site Number 250002, Paris

77900

Investigational Site Number 203001, Olomouc

92150

Investigational Site Number 250005, Suresnes

94160

Investigational Site Number 250018, Saint-Mandé

94800

Investigational Site Number 250001, Villejuif

BE-6000

Investigational Site Number 056006, Charleroi

Unknown

Investigational Site Number 250016, Reims

Investigational Site Number 372001, Dublin

Investigational Site Number 372003, Dublin

Investigational Site Number 380005, Candiolo

Investigational Site Number 380009, Meldola

Investigational Site Number 380006, Napoli

Investigational Site Number 380002, Pisa

Investigational Site Number 380008, Verona

07747

Investigational Site Number 276026, Jena

00152

Investigational Site Number 380001, Roma

4818CK

Investigational Site Number 528002, Breda

6525GA

Investigational Site Number 528003, Nijmegen

3015GD

Investigational Site Number 528005, Rotterdam

6162BG

Investigational Site Number 528004, Sittard-Geleen

08035

Investigational Site Number 724001, Barcelona

SM25PT

Investigational Site Number 826001, Sutton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY